API | Australian Securities Exchange

Australian Pharmaceutical
+ Share

Australian Pharmaceutical has initiated a positive momentum of 0.08
Momentum /
Australian Pharmaceutical has initiated a positive momentum of 0.08

API: MOM Current Signal -> (1) 14 Dec: BULLISH CROSSOVER (2) 13 Dec: BEARISH (3) 12 Dec: BEARISH

Closing price for Australian Pharmaceutical has seen buyers win the daily battle for performance @ 8.5%
Close Tod Vs Close Yest /
Closing price for Australian Pharmaceutical has seen buyers win the daily battle for performance @ 8.5%

[BULLISH]: Australian Pharmaceuticalbuyers are currently keener than sellers and are driving the price up. This is the first day of price rise for API adding strength to an uptrend change in the first timeframe. The biggest upward movement this month has been 8.5 & the greatest daily positive change this year has been 8.5. The longest consecutive upswing rally over the last 12 months has been 8 days giving a total rally upward movement of 26.8%. This quarter, the largest upswing rally has been 4 days giving a total rally upward movement of 8.5%. The win ratio for price rise in the first timeframe for the last 12 months is 0x giving a total win/loss ratio of 1x. Over the last month the average daily upward movement has been 3.600000%

Triangular Moving Average /
The TMA trend following signal is now active for Australian Pharmaceutical [Bullish]

[BULLISH]: Australian Pharmaceutical currently has a confirmed uptrend. Recent trading has caused the TMA 15 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on TMA15 is 8.5%.

Ease of Movement /
Trading session closed higher on high volume for Australian Pharmaceutical [Bullish]

[BULLISH]: Australian Pharmaceutical current price have moved upwards on high volume. Currently, the Ease of Movement is 0.346

Three White Soldiers /
Australian Pharmaceutical: Three White Soldiers

[BULLISH]: Australian Pharmaceutical has formed a new Three White Soldiers pattern.

Elders Force Index /
Bullish conditions for API have commenced based on EFI (31335)

[BULLISH]: Australian Pharmaceutical current price has highlighted recent buying pressure. Currently, the Elders Force Index is 31335.

Australian Pharmaceutical: Ulcer Index 5.232 [High Stress]
Ulcer Index /
Australian Pharmaceutical: Ulcer Index 5.232 [High Stress]

[BULLISH]: Australian Pharmaceutical UIX index implies that the downside risk of the current trading price is high. Currently, the UIX is 5.232.

Fibonacci Fans /
Australian Pharmaceutical is still above the 61.8% retracement fan level ($0.71) [Bullish]

Australian Pharmaceutical is still above the 61.8% retracement level ($0.71) [Bullish]. Look for a long limit order entry near this point. Exit price for API should be set @$0.445 & Stoploss for Australian Pharmaceutical should be set between $0.44

Daily bar has confirmed has confirmed an ATR uptrend is intact for API
Average True Range /
Daily bar has confirmed has confirmed an ATR uptrend is intact for API

[Bullish]: Average True Range has confirmed an uptrend is present. Australian Pharmaceutical has a TR of 0.225, and an ATR(14) of 0.062.

Initiation of overbought signal for Australian Pharmaceutical
Moving Average Envelope /
Initiation of overbought signal for Australian Pharmaceutical

[BULLISH CROSSOVER]: Australian Pharmaceutical current price has driven Envelope Bands to become overbought signalling the continuation of bullish rally likely Currently, the Upper Band is 1.5855.

Commodity Channel Index /
Initiation of an overbought CCI signal for Australian Pharmaceutical

API: CCI Current Signal ->(1) 14 Dec: BEARISH CROSSOVER (2) 13 Dec: NEUTRAL (3) 12 Dec: BEARISH CROSSUNDER

Simple Moving Average /
The SMA trend following signal is now active for Australian Pharmaceutical [Bullish]

[BULLISH]: Australian Pharmaceutical currently has a confirmed uptrend. Recent trading has caused the SMA 15 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SMA15 is 8.5%.

Rate of Change /
Rate of change(14) is now increasing for Australian Pharmaceutical

[BULLISH CROSSOVER]: Australian Pharmaceutical currently has positive rate of change of 5.281%. This means the current price is greater than the price 14 days ago and therefore gaining momentum & is a leading indicator of price movement in the upward direction

Australian Pharmaceutical: Percentage Volume Oscillator (5.16)
Percentage Volume /
Australian Pharmaceutical: Percentage Volume Oscillator (5.16)

[BULLISH CROSSOVER]: Australian Pharmaceutical currently has positive PVO 5.16%. The recent volume is gaining momentum through a rise on the short term exponential moving average. Currently, the return on PVO is 0%.

Australian Pharmaceutical has broken the first Camarilla resistance point ($1.855) [Bullish]
Camarilla Pivot Points /
Australian Pharmaceutical has broken the first Camarilla resistance point ($1.855) [Bullish]

Australian Pharmaceutical has broken the first Camarilla resistance point ($1.855) [Bullish]. Look for a long limit order entry near this point. Exit price for API should be set @$1.855 & Stoploss for Australian Pharmaceutical should be set between $1.336 & $1.206

Elder Ray Index /
[Bullish]: Elder Ray Index is 0.153 indicating bull power

[BULLISH]: Australian Pharmaceutical Elder Ray Index is signalling a Bullish movementERI is 0.153 indicating bull power. Prices are being driven above the consensus of value for API during the last trading session [Buying Pressure]

Sine Weighted Moving Average /
Price is now trading above the Sine Weighted Moving Average(15) for API

[BULLISH]: Australian Pharmaceutical currently has a confirmed uptrend. Recent trading has caused the SWMA 15 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SWMA15 is 8.5%.

Daily Volume Index /
API.AX: Current trading activity signals DVI accumulation has commenced

API: DVI Current Signal -> (1) 14 Dec: BULLISH CROSSOVER (2) 13 Dec: BEARISH (3) 12 Dec: BEARISH

Australian Pharmaceutical: Supertrend (1.617)
Supertrend /
Australian Pharmaceutical: Supertrend (1.617)

[BEARISH]: Australian Pharmaceutical has a current Supertrend of 1.617. This has change 0 points from yesterday.

Price is now above the displaced moving average for API [Bullish]
Detrended Price Oscillator /
Price is now above the displaced moving average for API [Bullish]

[BULLISH]: Australian Pharmaceutical currently has a confirmed uptrend. Price is currently above the displaced moving average for API. Currently, the return on DPO20 is 8.5%.

Closing price for API has crossed below the Lower Bollinger Band triggering a bullish crossover signal
Bollinger Bands /
Closing price for API has crossed below the Lower Bollinger Band triggering a bullish crossover signal

[BULLISH CROSSOVER]: Australian Pharmaceutical has initiated an oversold signal, highlighting the potential for a short term trend reversal in the upward direction. The current level is 116.68% with a current width of 9.93.

Key Reversal /
A short term Key Reversal has formed with Australian Pharmaceutical

[BULLISH]: A short term Key Reversal has formed with Australian Pharmaceutical which confirms the presence of a bullish bar reversal. Over the last 12 months there have been 1 occurrences of this bar reversal giving a signal probability of 0.4%.

Chaikin Money Flow /
CMF highlights continued negative divergence for Australian Pharmaceutical

[BEARISH]: Australian Pharmaceutical current price has highlighted recent selling pressure and the continuation of a bearish trading conditions. Currently, the CMF is -0.03. Australian Pharmaceutical (ASX:API) received a confirmed CMF crossover days on the Dec 4 2018. The bearish signal has been active for 0 day. During the quarter, the lowest CMF value was -0.17 occurring on the Dec 4 2018.

Exponential Moving Average /
Exponential Moving Average(15) signal is confirmed for Australian Pharmaceutical indicating upward price movement is likely

[BULLISH]: Australian Pharmaceutical currently has a confirmed uptrend. Recent trading has caused the EMA 15 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on EMA15 is 8.5%.

Pivot Points /
Stoploss for Australian Pharmaceutical should be set between $1.3320 & $1.239

Australian Pharmaceutical has broken the first resistance point ($1.782) [Bullish]. Look for a long limit order entry near this point. Exit price for API should be set @$1.782 & Stoploss for Australian Pharmaceutical should be set between $1.332 & $1.239

Traders are currently accumulating Australian Pharmaceutical
On Balance Volume /
Traders are currently accumulating Australian Pharmaceutical

[BULLISH]: Australian Pharmaceutical current price has highlighted recent accumulation. Currently, the OBV is 116649.

Trading for Australian Pharmaceutical highlights the commitment of buyers to carry positions overnight.
Close Tod Vs Range Tod /
Trading for Australian Pharmaceutical highlights the commitment of buyers to carry positions overnight.

[BULLISH]: Australian Pharmaceutical buyers are in control at the market close. This is the first day of buyer commitment for Australian Pharmaceutical adding strength to an uptrend in the first timeframe & highlights the commitment of buyers to carry positions overnight. Over the last 12 months there has been 4 trading days with the closing price in the upper part of the range giving a confirmation ratio of 1.5%. Over the last month there has been 4 trading days with the closing price in the upper range giving a confirmation ratio of 40%. Currently this quarter, closing price has spent 4 days in the upper price range compared to 2 days in the lower range giving a ratio of 2x.

Long White Candle /
API Basic Candle: Long White

[BULLISH]: Australian Pharmaceutical has formed a Long White candlestick. This means, API has traded with strong buying pressure throughout the day adding strength to previous short term trends. Given the limited timeframe in which signal has formed, further confirmation is required through volume and additional technical indicators.

See More   See more results
back to top